Navigation Links
Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
Date:9/30/2009

LAKE FOREST, Ill., Sept. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced the acquisition of worldwide rights to a biogeneric version of filgrastim and an affiliated European manufacturing facility from PLIVA Hrvatska d.o.o. (Zagreb, Croatia) (ZSE: PLVA-R-A), a move that will help extend Hospira's reach and vertical integration in biogenerics. Financial terms of the agreement were not disclosed.

As a result of the acquisition, Hospira will now have full global rights to the biogeneric filgrastim that had previously been part of a strategic collaboration between Hospira and PLIVA/Barr, the latter two companies now owned by Teva Pharmaceutical Industries Ltd.

As part of the agreement, Hospira has also acquired process development capabilities and a manufacturing plant in Croatia. The site has capacity sufficient to meet Hospira's worldwide filgrastim and pegfilgrastim requirements, along with expansion possibility for additional biogenerics manufacturing.

"With this agreement, Hospira expands its reach to new markets for filgrastim, and its global manufacturing capacity for pegfilgrastim," said Ron Squarer, senior vice president, Global Marketing and Corporate Development, Hospira. "Hospira is already well-positioned in the biogenerics marketplace, given our internal capabilities, our strategic collaborations and our commercialization experience in Europe. The additional vertical integration this deal brings, as well as the access to broader markets for our products, further demonstrates Hospira's robust commitment to the biogenerics space."

Applications for product approval of filgrastim were filed with the European Medicines Agency (EMEA) and Australia's Therapeutic Goods Administration (TGA) in the first quarter of
'/>"/>

SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
3. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. U.S. Preventive Medicine Acquires Specialty Disease Management
6. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
9. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
10. Worldwide Sensation: "A"- Implant Novelty From Austria
11. Worldwide Cost Estimate for Alzheimers and Dementia Is US$315.4 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... CITY, Calif. , Nov. 26, 2014  Genomic ... Kim Popovits , Chairman, Chief Executive Officer and ... Piper Jaffray Healthcare Conference at The New York Palace ... Wednesday, December 3 at 11:30 am Eastern Time (ET). ... webcast of the conference call, go to the  Investor ...
(Date:11/26/2014)... Nov. 26, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... Food and Drug Administration (FDA) has issued a ... (NDA) for AVP-825. AVP-825 is an investigational drug-device ... intranasally utilizing a novel Breath Powered delivery technology. ... and consistent with the preliminary feedback announced on ...
(Date:11/26/2014)... 2014 Scott Steiger lives in ... As an engineer for the past 20 years, he,s traveled extensively ... service. He,s been to six of the seven continents. Travel is ... http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... a pretty good idea of what,s required. His latest ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Steiger Has Created the First Pill Case Specifically Designed For Travel 2
(Date:11/29/2014)... 29, 2014 Syntermed, Inc. announces availability ... product for the U.S. nuclear medicine market ... Chicago, IL. , “NeuroQ is well established ... the quantitation of PET- FDG and Amyloid brain ... step,” announced Michael Lee, CEO, Syntermed, Inc. “Radiologists and ...
(Date:11/28/2014)... (PRWEB) November 29, 2014 North America ... by Europe. The U.S. market is highly supported by ... researches in different clinical institutes such as National Cancer ... the Asia-Pacific region is expected to show a remarkable ... of the World are poised to grow at a ...
(Date:11/28/2014)... Lunadress.co.uk, one of the world’s leading suppliers ... released its fashionable white prom gowns. These new ... low price. The company provides a big discount of ... shipping for orders over 99 pounds. , LunaDress provides ... representatives if needed. The kind experts will explain the ...
(Date:11/28/2014)... Tbdress.com has recently announced ... online on Nov. 28, 2014. The special offer will ... many more) at greatly discounted prices. , The ... cultural holiday, celebrated generally on December 25 by billions ... Christmas sales, are always provided in December.” , ...
(Date:11/28/2014)... sells cheap tall cocktail dresses worldwide and ... there is a new collection of tall cocktail dresses ... at very low prices. It is really worthy to ... by UWDress.com , UWDress.com is one of the most ... has the power to ensure customer satisfaction. Now, the ...
Breaking Medicine News(10 mins):Health News:Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging Announced at RSNA 2Health News:Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging Announced at RSNA 3Health News:Researchmoz : Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020 2Health News:Researchmoz : Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020 3Health News:LunaDress.co.uk: New White LunaDress Prom Gowns Online for Sale Now 2Health News:Tbdress.com Announced Its Christmas Eve Sales 2Health News:Graceful Tall Cocktail Dresses With New Features Just Added To UWDress.com 2
... achieved such a central place in public consciousness as ... it is a feared weapon of bioterrorism Bacillus anthracis ... research of the celebrated 19th century scientists Robert Koch ... diseases and immunology In his new book Bacillus ...
... are reporting the development of a new, ultra-light form ... solid material with amazing strength and an incredibly ... (MCNT) aerogel" could be used in sensors to detect ... A report about the material appears in ACS ...
... more persistent memory of fear conditioning - acquired by ... and lack the ability to inhibit this fear. This ... from Post-Traumatic Stress Disorder (PTSD), an anxiety disorder which ... as a violent attack, a natural disaster or physical ...
... kilos you,ve put on over Christmas, you may be interested in ... in your likelihood of regaining weight after dieting. A new study ... levels of ghrelin are more likely to put the centimetres they ... patients who, after sticking to a slimming diet, have regained the ...
... vital tumor-suppressing mechanism that is often broken in malignant ... goes haywire to stimulate cancer growth have earned two ... Center membership in a distinguished association of scholars. ... and chair of MD Anderson,s Department of Molecular and ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Jan. ... heart failure patients taking the blood pressure drug candesartan stood ... Swedish researchers report. In fact, 61 percent of those ... taking losartan (Cozaar); this difference may be due to differences ...
Cached Medicine News:Health News:'Bacillus anthracis and Anthrax' 2Health News:Drug reduces the increase in fear caused by previous traumatic experiences in mice 2Health News:'Yo-yo' effect of slimming diets explained 2Health News:Peers elect MD Anderson's Hung and Lozano as Fellows of AAAS 2Health News:Peers elect MD Anderson's Hung and Lozano as Fellows of AAAS 3Health News:Not All Heart Failure Drugs Boost Survival Equally 2
... Korchek Technologies CareChek Tx, ... as a software device for ... to match the patient to ... the bedside before administering a ...
... 140XiIII is the fastest barcoding printer ... such powerful performance and steel construction, ... high-volume, mission-critical applications with 24-hour duty ... for applications in which labels are ...
... you use technology that improves patient outcomes. ... simple-to-use BD.id Patient Identification System for Specimen ... the specimen container, and the order of ... only for specimens actually collected, with both ...
... ID verification and laboratory specimen labeling system uses ... phlebotomist or nurse, the identity of the patient ... is made, a bar coded sample ID label ... design simplifies and eliminates the interface problems inherent ...
Medicine Products: